Discover Generation Bio's groundbreaking advancement in genetic medicine with their proprietary immune-quiet DNA (iqDNA). Promising results in preclinical studies.
Get the latest news on Nkarta's groundbreaking FDA-approved CAR NK cell therapy trial for lupus nephritis. Promising treatment option for refractory LN patients.
Get the latest news on Nkarta's groundbreaking FDA-approved CAR NK cell therapy trial for lupus nephritis. Promising treatment option for refractory LN patients.